Dandelion Health, a New York-based clinical intelligence platform for life sciences, has raised $14 million in Series A funding.
Investors
The round was led by Healthier Capital, with participation from Colle Capital, Primary Venture Partners, Moxxie Ventures, and Convergent Ventures.
Healthier Capital is a U.S.-based venture capital firm focused on healthcare technology and digital health startups. Based in Menlo Park, California, the firm invests in early-stage companies that use technology, AI, data infrastructure, automation, and modern care delivery models to improve healthcare outcomes and efficiency.
Dandelion Health Use of Funds
The company will use the funding to expand pharmaceutical partnerships, scale its data and engineering infrastructure, and grow its commercial and scientific teams.
About Dandelion Health
Dandelion Health is a clinical intelligence platform that uses multimodal AI and large-scale patient data to support life sciences research, drug development, and precision medicine. The company integrates structured healthcare data, such as electronic medical records and claims data, with unstructured clinical text and raw biological signals, including ECGs, radiology imaging, echocardiograms, ultrasounds, and pulmonary tests. Dandelion supports partners throughout the drug development lifecycle, from discovery through commercialization. Headquartered in New York, Dandelion operates across a network of 73 hospitals.
Funding Details
Company: Dandelion Health, Inc.
Raised: $14.0M
Round: Series A
Funding Date: May 2026
Lead Investor: Healthier Capital
Additional Investors: Colle Capital, Primary Venture Partners, Moxxie Ventures, and Convergent Ventures
Company Website: https://dandelionhealth.ai/
Software Category: Clinical AI / Healthcare Data Intelligence Platform
Source: https://www.prweb.com/releases/dandelion-health-raises-14-million-series-a-to-advance-multimodal-clinical-ai-platform-for-life-sciences-and-ai-development-302762022.html